When Hims launched in 2017, they promised to revolutionize men's health with sleek branding and convenient telemedicine. But beneath the millennial-friendly packaging lies a surprising truth: they're selling the same hair loss drugs your father could have bought in 1997.
The Hims Formula: Old Wine in New Bottles
Hims offers various combinations of two FDA-approved ingredients: finasteride (approved 1997) and minoxidil (approved 1988). Their product line includes:
- Oral finasteride tablets (1mg daily)
- Topical finasteride spray (0.3%)
- Minoxidil solution and foam (5%)
- Combination sprays with both ingredients
At $35-50 per month, Hims essentially acts as a middleman between you and generic drugs that have been available for decades. But the real question isn't about convenience—it's about effectiveness.
The Fundamental Flaw: Poor Absorption Rates
Key Statistic
Only 1-3% of topically applied minoxidil penetrates the scalp barrier, according to published pharmaceutical data.
Hims claims their topical finasteride reduces systemic exposure compared to oral tablets. While true, this admission reveals the core problem: if the medication isn't entering your bloodstream, it's also not reaching your hair follicles effectively.
Why Traditional Topicals Fail
| Barrier | Impact on Absorption | Hims' Solution |
|---|---|---|
| Stratum Corneum | Blocks 97% of topical molecules | None - same formulation as generics |
| Molecular Size | Minoxidil too large for easy penetration | Cannot change molecular structure |
| Lipid Barrier | Repels water-based solutions | Standard alcohol carriers |
| Enzymatic Breakdown | Degrades active ingredients on skin surface | No protective mechanism |
The Side Effect Dilemma
By offering both oral and topical options, Hims inadvertently highlights the impossible choice facing hair loss sufferers:
Oral Finasteride: Effective but Risky
FDA Warnings for Finasteride Include:
- Sexual dysfunction in up to 3% of users ( FDA Label )
- Depression and suicidal ideation (added 2022)
- Post-Finasteride Syndrome affecting 1.2% of users
- Potential permanent side effects even after discontinuation
Topical Formulations: Safer but Less Effective
Hims' topical finasteride spray (0.3%) promises reduced side effects, but this comes at the cost of effectiveness. If the drug isn't entering your system, it's also not reaching the deeper follicle structures where DHT production occurs.
What the Studies Actually Show
Hims frequently cites impressive statistics, but a closer look reveals limitations:
"91% of men saw improvement after 5 years of finasteride use"
- Often quoted study from 1998
What they don't emphasize:
- "Improvement" often means slowed loss, not regrowth
- Results require continuous use—hair loss returns within months of stopping
- The study predates recognition of persistent side effects
- No data on their specific formulation combinations
The True Cost Analysis
| Treatment Option | Monthly Cost | Annual Cost | Hidden Costs |
|---|---|---|---|
| Hims Finasteride | $35-40 | $420-480 | Lifetime commitment, potential side effects |
| Hims Minoxidil | $15-25 | $180-300 | Twice daily application forever |
| Hims Combination | $45-50 | $540-600 | Compounded risks and commitments |
| Generic Equivalents | $10-30 | $120-360 | Same limitations as Hims |
The Micro-Infusion Breakthrough
While Hims repackages old solutions, advances in delivery technology have revolutionized how treatments reach hair follicles. Micro-infusion technology creates temporary micro-channels that bypass the skin barrier entirely.
How Micro-Infusion Differs from Traditional Topicals
Traditional Topicals (Like Hims)
- Sit on skin surface
- 1-3% absorption rate
- Blocked by natural barriers
- Require harsh penetration enhancers
Micro-Infusion Technology
- Direct follicle delivery
- 30× better absorption
- Bypasses skin barriers
- Activates natural healing response
The Science of Enhanced Delivery
Published research on micro-channel delivery shows:
- 30-fold increase in active ingredient penetration
- Direct access to dermal papilla where hair growth originates
- Activation of wound healing cascades that stimulate follicles
- Sustained therapeutic levels without systemic exposure
Making an Informed Choice
Hims deserves credit for making hair loss treatment more accessible and removing stigma through modern marketing. However, accessibility doesn't equal innovation. When choosing a hair loss treatment, consider:
- Actual Innovation vs. Repackaging: Are you paying for new technology or just new branding?
- Delivery Method: Does the treatment address the fundamental absorption problem?
- Risk vs. Reward: Are potential side effects worth modest results?
- Long-term Commitment: Can you maintain the regimen indefinitely?
Frequently Asked Questions
Q: Is Hims FDA approved?
A: Hims uses FDA-approved ingredients (finasteride and minoxidil), but their specific formulations and combinations are not separately FDA approved. The telemedicine platform operates under state medical regulations.
Q: Can I use Hims with other treatments?
A: While possible, combining treatments should be done under medical supervision. Adding more topicals doesn't solve the absorption problem—it may just increase irritation.
Q: Why do some people see results with Hims?
A: Finasteride and minoxidil do work for some users, particularly oral finasteride which achieves systemic DHT reduction. However, response rates vary, and the fundamental limitations remain.
Ready for a Better Solution?
Stop settling for repackaged drugs from the 1990s. NovaMane's micro-infusion technology delivers what traditional topicals can't—real penetration, real results.
The choice is yours: continue hoping that 40-year-old drugs will suddenly work better with new packaging, or embrace the scientifically-proven advancement of micro-infusion delivery. Your follicles don't care about branding—they care about actually receiving the treatment you're applying.